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Abstract (250/250) 
Objective: Antimicrobial wipes are increasingly used in healthcare settings. This study 
evaluates in a clinical setting the efficacy of sporicidal wipes vs. a cloth soaked in a 
1,000 ppm chlorine solution.  
 
Intervention: A double crossover study was performed on two different surgical and 
cardiovascular wards in a 1000-bed teaching hospital over 29 weeks. The intervention 
period which consisted of surface decontamination with the pre-impregnated wipe or 
cloth soaked in chlorine followed a 5-week baseline assessment of microbial 
bioburden on surfaces. Environmental samples from 11 surfaces were analyzed 
weekly for their microbial content. 
 
Results: A total of 1566 environmental samples and 1591 ATP swabs were analyzed 
during the trial. Overall, there were significant differences in the recovery of total 
aerobic bacteria (p<0.001), total anaerobic bacteria (p<0.001) and ATP measurement 
(p<0.001) between wards, and between the different parts of the crossover study. 
Generally, the use of wipes produced the largest reduction in the total aerobic and 
anaerobic counts when compared to the baseline data or the use of 1,000 ppm 
chlorine. Collectively the introduction of training plus daily wipe disinfection 
significantly reduced multidrug resistant organisms recovered from surfaces. 
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Reversion to using 1,000 ppm chlorine saw the number of sites positive for MDRO rise 
again. 
 
Conclusions: This double crossover study is the first controlled field trial comparison 
of using pre-impregnated wipes vs. cotton cloth dipped into a bucket of hypochlorite 
to decrease surface microbial bioburden. The results demonstrate the superiority of 
the pre-impregnated wipes in significantly decreasing microbial bioburden from high 
touch surfaces. 
 
 
Keywords: wipes, hypochlorite, double-crossover trial, disinfection 
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INTRODUCTION 
Multidrug resistant organisms (MDRO) are commonly associated with healthcare-
associated infections (HCAIs). MDRO have a significant impact on patient morbidity 
and mortality and represent a substantial financial burden.1-3 Hospital surfaces can be 
persistent reservoirs for HCAIs.4-8 Patients admitted to a room previously occupied by 
a patient with MDRO have an increased risk of acquiring these pathogens.9-12 The use 
of wipe or cloth in association with liquid/spray/vaporised disinfectants is becoming a 
common method to apply disinfectants to hospital surfaces.13 Pre-impregnated wipes 
are increasingly being used for hospital cleaning/disinfection because of their ease of 
use and activity claims.13 Whilst the majority of studies investigating pre-impregnated 
wipes have focused on in vitro studies,14-19 there is a limited number of studies that 
have assessed the efficacy of wipes for surface cleaning/disinfection in a clinical 
setting.20-23 To date, no study has evaluated the comparative effectiveness of pre-
impregnated wipes against a disinfectant solution.   
 
Our primary objective was to evaluate whether daily use of a peracetic acid/hydrogen 
peroxide pre-impregnated wipe in place of the existing standard practice (detergent 
cleaning with cloth soaked in a 1,000ppm chlorine containing bucket) lead to a 
significant reduction in surface microbial contaminants. 
 
Methods:  
Setting 
This study was conducted on two identical surgical and cardiovascular wards in a 
1000-bed teaching hospital over a 29 weeks period between August 2013 and April 
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2014. Following a 5-week baseline period (using a combination of detergent cleaning 
with cloth soaked in a 1,000ppm chlorine (Baseline), a 24 weeks double crossover 
study was conducted (Phases 1 and 2; Figure 1) to assess the efficacy of the standard 
practice of chlorine disinfection with a cloth versus the introduction of a peracetic 
acid/hydrogen peroxide wipe.  
 
Cleaning/disinfection protocol 
For the purpose of this study, 1,000 ppm chlorine solution in a bucket was used in 
combination with cotton cloths following a detergent cleaning step for all the surfaces 
sampled. The disinfectant wipe was a dry pre-impregnated (sporicidal) wipe, which 
generates peracetic acid/hydrogen peroxide when activated with water. The number 
of wipes required per surface was determined depending on the surface area 
according to the manufacturer’s instructions. Procurement of wipes was calculated on 
expected usage per wards per week. To ensure the correct product was used during 
the intervention period, all detergent and chlorine containing agents were removed 
from the specified ward.   
 
Training 
Training (approved by the IPC team) was delivered to nurses, healthcare assistants 
and environmental services cleaning staff, including supervisors. Training was 
conducted over a 2-week period, in groups of 1-5 staff, for 30-45 minutes before both 
intervention periods (Figure 1).  
 
Environmental sampling  
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Surface samples were collected weekly from 11 sites (bed control, bed rails, tray table, 
call button, patient chair, drug locker, commode top, bathroom door handle, flush 
handle, toilet grab rail and toilet seat) between 6 and 7 am, prior to cleaning. Locations 
included ward, isolation rooms, four-bedded bays, single and shared bathrooms, and 
sluice room. 
A 10 x 10 cm2 sterile template (ThermoFisher, UK) was placed on surfaces where 
possible. Surfaces were wiped with a pre-moistened (neutralizing buffer) cellulose 
sponge (3M™ Sponge-Stick, UK) under aseptic conditions.  Sponge-Sticks were 
applied firmly 3 times horizontally and 3 times vertically on each side of the sponge so 
that the designated area was sampled. For the call button, the entire surface (front, 
back and sides) was sampled; for the toilet flush handle, the flush handle itself and 
area immediately surrounding the flush handle was sampled. 
 
Sponge heads were placed in individually sealed bags and transported within 3 h of 
sampling.  Handles were aseptically removed, and sponges processed following the 
method of Dubberke et al.24 with the following modifications: excess liquid was 
aseptically squeezed into the stomacher bag which were placed in a stomacher®400 
(Seward Stomacher, UK) and homogenized for 15 min at room temperature. The 
volume of homogenized liquid was measured to the nearest decimal point with a 10 
mL stripette and placed into a 50 mL centrifuge tube. 
  
Total aerobic and anaerobic counts 
A 100 µL sample was plated onto Brain Heart Infusion Agar (BHI; Oxoid Ltd, UK), 
incubated at 37°C for 72 h for aerobic colony counts.  For anaerobic colony counts 
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pre-reduced BHI agar was inoculated and incubated in an anaerobic workstation 
(MG500; DW Scientific, UK) for 72 h. All the results were expressed as total 
aerobic/anaerobic count (in colony-forming units [CFUs]) per cm2 of sampled surface. 
 
Indicator Microorganisms  
The presence of MRSA, VRE, ESBL, CRE and C. difficile on environmental surfaces 
was monitored by inoculating 10 µL of each sample onto the appropriate selective 
culture media including Brilliance MRSA 2 Agar, Brilliance VRE Agar, Brilliance ESBL 
Agar and Brilliance CRE Agar (Oxoid Ltd, UK).  
 
For C. difficile a two stage process was undertaken: i) direct inoculation onto pre-
reduced Cefoxitin Cycloserine Fastidious Anaerobe Agar (CCFA) (LabM) 
supplemented with 5 mg/mL lysozyme (Sigma-Aldrich UK), 1% (w/v) sodium 
taurocholate (Sigma-Aldrich UK)  and 1% (v/v) defibrinated sheep blood (VH Bio Ltd, 
UK) and ii) post-enrichment inoculation – following anaerobic incubation of samples 
for 72 h, tubes were centrifuged at 5,000 g for 5 mins at 4°C, re-suspended in 80 % 
(v/v) absolute ethanol and held for 1 h at room temperature. Following ethanol shock 
samples were centrifuged, re-suspended in 2 mL sterile de-ionised water and heat 
shocked for 20 min at 60°C. Samples were allowed to cool to room temperature and 
10 µL plated onto CCFA supplemented with 5 mg/mL lysozyme, 1% (w/v) sodium 
taurocholate and 1% (v/v) defibrinated sheep blood and incubated anaerobically for 
72 h. All isolates that were recovered from the chromogenic selective media were sub-
cultured and identified as per the manufacturer’s instructions. Growth or colonies with 
colors other than those specified in the manufacturer’s instructions were reported as 
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negative but were stored at -20°C for subsequent analysis. Colonies displaying the 
atypical morphology (large, irregular, ground glass appearance) and smell were 
recorded.  All isolates were sub-cultured and identified using the RapID ANA II system 
(Remel, Lenexa). All reactions were interpreted as described in the manufacturer’s 
interpretation guide. A positive control of C. difficile NCTC 11209 (PHE, UK) was 
included to aid in interpretation.  
 
Presumptive Staphylococci 
Colonies recovered from the Brilliance MRSA 2 Agar were identified using the API-
Staph identification kit according to the manufacturer’s instruction (BioMerieux, 
France). 
 
DNA extraction  
Colonies recovered from the Brilliance MRSA 2 Agar and those identified as C. difficile 
with the RapID ANA II system were subjected to further molecular testing. DNA was 
isolated using the GeneJET Genomic DNA purification kit (ThermoFisher, UK) as per 
the manufacturer’s instructions and stored at -20°C until further use.  DNA purity and 
concentration were measured using a NanoDrop™ (Thermo Scientific, UK). For C. 
difficile, samples were ribotyped at the Anaerobic Reference Unit, Cardiff.    
 
Presumptive S. aureus colonies were further characterized by the presence of the spa 
fragment (180-600 bp) and mecC (138 bp) following the PCR method of Stegger et 
al.,25 mecA (533 bp) as outlined by Murakami et al.,26 and typed by RAPD following 
the method by Cheeseman et al.27 Gels were visualized under UV illumination using 
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the ChemiDoc™ XRS+ (Bio-Rad, UK). Digital files were standardized for band 
detection with the Image Lab (Bio-Rad, UK) software. All gels included DNA from 
control strains and a DNA ladder (GeneRuler 100 bp DNA Ladder, Thermo Scientific, 
UK). Control strains included mecA positive S. aureus NCTC 12493 (PHE, UK) and 
mecC positive S. aureus NCTC 13552 (PHE, UK).  
 
ATP Sampling 
Adenosine triphosphate sampling was performed with Ultrasnap swabs (SystemSure 
Plus system Hygiena® Int. Ltd, UK) following the manufacturer’s instructions. Prior to 
sampling the system was calibrated on a weekly basis using ATP positive and 
negative controls as per manufacturer’s instructions (Hygiena® Int. Ltd, UK). Where 
possible directly adjacent surfaces to microbiological sampling were sampled. For the 
flush handle, call button and bed control ATP samples were obtained before sampling 
with the sponge-sticks was conducted.  
 
Statistical Analysis 
Data were analyzed with a mixed effect model utilizing log10 (+1) transformed data of 
ATP (n = 1505), Aerobic (n = 1438) or Anaerobic (n = 1438) count as dependent 
variable. Ward, baseline and intervention periods, as well as an interaction term 
thereof, were used as independent variables. Repeated measures across weeks were 
accounted for in the random model. Step-wise model reduction was performed by 
comparing AIC values between full and reduced models. Standardized residuals from 
each model were first checked visually for normality and homogeneity of variance 
using a histogram, Q-Q plots and fitted values. To test for correlation between ATP 
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values and bacterial counts, a spearman rank correlation test was performed. All 
analyses were performed utilizing the nlme library in R 2.13.2 (R Development Core 
Team 2012). 
 
Results 
 
Environmental Sampling Results 
In total, 1566 environmental samples and 1591 ATP swabs were taken from the two 
wards. Ward 1 closed halfway through phase 2 (Figure 1) following a norovirus 
outbreak and underwent enhanced disinfection with sodium hypochlorite 5,000 ppm 
and twice daily cleaning. No samples were collected during this period.  
Overall, the use of pre-impregnated wipes produced the largest significant reduction 
in the total aerobic (p<0.001), anaerobic (p<0.001) counts and ATP RLU 
measurements (p<0.001) when compared to the baseline data (Figure 2). The overall 
reduction of aerobic counts (for all surfaces) was significantly higher (p<0.001) 
following the use of pre-impregnated wipes compared to the use of 1,000 ppm chlorine 
solution during the trial. The RLU count was significantly lower (LogATP p<0.001) 
following the use of pre-impregnated wipe rather the use of chlorine 1,000 ppm in ward 
2 only (Figure 2B). 
During the baseline study, a number of sites registered total aerobic and anaerobic 
count >2.5 cfu/cm2, whereas during the intervention period all sites showed a <2.5 
cfu/cm2 regardless of the wards. The introduction of training plus daily disinfection 
reduced the number of sites with RLU values >250 to 21 sites (8% of sites, compared 
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to 18% in the baseline period) and 19 sites (7% of sites, compared to 21% in the 
baseline period) for wards 1 and 2, respectively. 
In ward 1, the re-introduction of using detergent and chlorine (phase 2) following the 
use of pre-impregnated wipe (phase 1) so a significant increase (p<0.001) in aerobic 
count in some (toilet flush handle, tray table and locker) but not all sites sampled (figure 
3A). This increase was not as pronounced with the total anaerobic count (figure 3B). 
For the call button the number of aerobic and anaerobic counts continued to decrease 
in phase 2 (Figure 3). The introduction of pre-impregnated wipes (phase 2) following 
the use detergent and chlorine 1,000 ppm decreased significantly the total aerobic 
(p<0.001) and anaerobic (p<0.001) counts (Figure 4). The impact of staff training is 
shown in Figure 4, where a significant decrease (p<0.001) in total aerobic count or 
anaerobic count can be observed for the toilet seat and tray table between the baseline 
period and the use of detergent and chlorine (Figure 4). Other surfaces show a non-
significant decrease (p>0.001) in count between baseline and the use of detergent 
and chlorine   
 
Isolation of specific bacteria 
In the baseline period, 7% (35/522) of all sites sampled were positive for VRE, CRE 
or ESBL (Figure 5). The introduction of training and pre-impregnated wipes reduced 
this to 1% (5/522) (Phase 1; ward 1). Reversion to the use of detergent and 1,000 ppm 
chlorine saw the number of sites positive for VRE, CRE or ESBL rise to 3% 
(14/522)(Ward 1 phase 2), although this number was below that of the baseline for 
ward 1. For ward 2, training was effective in reducing the number of positive sites from 
13 to 7/522 (Ward 2, phase 1) and this number decreased further to 3 sites following 
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the use of pre-impregnated wipes (Figure 5B). Overall VRE was the most common 
isolated MDRO (6% of samples), primarily from toilet seat and toilet grab rail (data not 
shown). 
Collectively a large number of confirmed staphylococci (280/1566) were recovered, 
the majority of which were S. haemolyticus (45%) and S. aureus (25%). For S. aureus, 
58% of isolates were positive for mecA, 30% for mecC and 40% for spaA. For S. 
haemolyticus 66 % were positive for mecA, 11% for mecC and 29% for spaA (data not 
shown). 
Of the 1566 environmental samples obtained, only 45 cultures (3%) were identified as 
C. difficile following the post-enrichment step. C. difficile counts increased in both 
wards during phase 2 regardless of the intervention (data not shown). All isolates were 
confirmed to be typed as RT001 (data not shown). No RT001 was however reported 
for the clinical samples submitted for ribotyping during the trial period. The 
predominant ribotype at the time was RT027 followed by RT020 (communication from 
Trefor Morris, UK anaerobe reference unit Public Health Wales). Other anaerobic 
bacteria were identified (data not shown).  
 
Discussion 
 
This double crossover study is the first controlled field trial comparison of the use of 
pre-impregnated wipes vs. cotton cloth dipped into a bucket of hypochlorite to 
decreasing surface microbial bioburden in two surgical and cardiovascular wards. 
Here we showed that pre-impregnated wipes contributed to significantly decreasing 
microbial bioburden from a number of high touch surfaces. The number of sites with 
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identified MDRO also decreased significantly following the use of the pre-impregnated 
wipes. In ward 1, results showed an initial significant decrease in microbial bioburden 
where the wipes were used immediately after the baseline (phase 1), followed by an 
increase in microbial count following the re-introduction of cotton cloth dipped into a 
bucket of 1,000 ppm chlorine solution (phase 2). In ward 2, the use of the pre-
impregnated wipes in phase 2 contributed to a further reduction (statistically significant 
for a number of surfaces) of microbial count on surfaces. During the intervention period 
an average of 150 and 175 wipes were used per day on wards 1 and 2, respectively. 
It was not possible to collect data on the average number of cleaning cloths used 
during the baseline period as the type of cloth used for cleaning and disinfection 
ranged from re-usable microfiber to disposable cotton cloths. Given the estimated wipe 
usage, the ward layout out and the number of surfaces on the 38-bed wards it would 
appear that a ‘one-wipe-one-direction-one-surface’ recommendation was not strictly 
adhered to. In spite of this, a significant reduction in total microbial counts was 
observed when the intervention product was used. The efficacy of the pre-impregnated 
wipe may be due to its ability to retain and not transfer microbial burden to multiple 
surfaces, as demonstrated in an earlier laboratory study.16 A recent crossover trial 
highlighted the superiority of using pre-formulated wipe with an oxidizing chemistry 
against the use of a quaternary ammonium compound-based wipe in significantly 
reducing surface contamination.23 It has been suggested that aerobic colony count on 
hand touch surfaces should not exceed 5 CFU/cm2, although a “clean’ cut-off point of 
<2.5 CFU/cm2 has been proposed.28-30 With this in mind,  a number of surfaces in the 
baseline period would not be considered as “clean”. The intervention resulted in all 
surfaces passing a <2.5 CFU/cm2.  Boyce and Havill reported that the use of a new 
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hydrogen peroxide wipe lead to 99% of surfaces treated with <2.5 cfu/cm2 following 
surface cleaning.20 In our study, it is encouraging that the use of pre-impregnated 
wipes achieved the cut-off points considering that sampling was performed once a 
week and before cleaning.  
Sporicidal wipes are designed to eliminate spores of C. difficile on surfaces. Here, very 
few C. difficile spore (genotype RT001) were recovered overall, while all the clinical C. 
difficile were of the RT027 and RT020 ribotypes at the time of study. Introducing 
sporicidal wipes to control C. difficile outbreaks has been reported in one study, in 
which replacing the use of hypochlorite with a pre-impregnated sporicidal wipe led to 
a significant reduction in C. difficile infection rate over time.21  
Here, the efficacy in reducing surface bioburden from combining a hypochlorite 
solution and cotton cloths was inferior to the pre-impregnated wipes. The use of 
hypochlorite-formulated wipes has however been showed to contribute significantly to 
the decrease of C. difficile infection,22 although pre-formulated hypochlorite wipe can 
potentially transferred microorganisms between surfaces.18 These studies and ours 
highlight that pre-formulated wipes for which the disinfectant solution and the wipe 
material are optimized for activity, have a better efficacy.  
It is clear that product efficacy and the appropriate use of wipes as well as staff training 
and product usage auditing are essential.2,31 Although staff awareness of the trial 
might have contributed to the observed improved performance,23,32 the introduction of 
specific training has undoubtedly had an impact. Here, training saw an average 17% 
reduction in the mean total aerobic count in both wards, although the introduction of 
wipe saw a 34 and 40% reduction in the mean total aerobic count in wards 1 and 2 
respectively. Measurement of RLU using an ATP sampler to indicate surface 
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cleanliness in healthcare setting is not new.28,33,34 In our study, a Spearman’s rank 
correlation test identified total aerobic count (cfu/cm2 log10+1) and ATP (RLU) to be 
highly correlated (p-value < 0.0000). By log transforming the ATP data, a more even 
distribution was achieved although the data was still not normally distributed. Our 
results however support the data presented by Boyce and Havill who observed a good 
correlation between total aerobic count and ATP measurement.20 
 
The cost effectiveness in using formulated wipe products need to be justified. The use 
of formulated wipes offers many advantages compare to the practice of using 
hypochlorite solution in a bucket. These include i) a better control of microbial 
bioburden, ii) ease of use, avoiding the use of highly concentrated biocidal solutions 
to be diluted down, iii) increasing efficacy by optimizing the combination between the 
disinfectant solution and the wipe material, iv) compatibility with, and decreasing 
damages to, the surfaces to be wiped, v) decreasing time required to disinfect the 
patient room/ward, vi) avoiding contaminating the disinfecting solution / product 
following repeated use and vii) the provision of clear instructions on label, including 
support instructions/posters, training packages by the manufacturer. Of these 
advantages, eliminating the risk of human error during product preparation / dilution is 
attractive since a decrease in biocidal product concentration can affect bacterial 
survival, resistance and cross-resistance to antimicrobials.35,36 In addition,  optimizing 
the disinfectant solution with the appropriate wipe materials not only increases the 
efficacy in removing microbial burden from surfaces, but also decreases microbial 
transfer if a wipe is misused on multiple surfaces.13,14,18 
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There were several limitations in our study. We did not measure the impact of other 
hygiene measures, such as hand washing. The diversities of patients and patient 
length of stay on the two wards, the inability to measure the antimicrobials used on the 
wards on the daily/weekly basis (there was no significant difference (p>0.05) in the 
monthly antimicrobial stock data between phases and/or wards for both systemic and 
topical antimicrobials), and the inability to get accurate figure of patient infection rate 
for just the trial period, impinged on demonstrating further benefits from the use of pre-
impregnated wipes.  
 
In conclusion, this crossover trial demonstrated that the use of a pre-impregnated wipe 
product provided a better control of microbial burden on surfaces, simplified 
disinfection procedures, and questioned the practice of using hypochlorite diluted 
solution in a bucket in combination with some cloth materials.    
 
Acknowledgement 
The authors wish to thank Dr B. Schelkle (Cardiff University) for her help in the 
statistical analysis of the results, T. Morris (UK anaerobe reference unit, Public Health 
Wales) for the ribotyping of the C. difficile isolates, J. Otter (Imperial College London) 
and M Kiernan (GAMA Healthcare) for their constructive comments about the study.  
 
Financial support 
This study was supported by Innovate UK as part of Knowledge Transfer Partnership 
(KTP008770) between Cardiff University and GAMA Healthcare Ltd. 
 
 
 
 
17 
Conflict of interest: H Siani was the recipient of the Knowledge Transfer Partnership. 
The authors have no conflict of interest to declare. 
 
 
 
 
18 
References  
 
1. Siegel JD, Rhinehart E, Jackson, et al. Management of multidrug-resistant organisms 
in health care settings. Am J Infect Control 2007;35:S165-193. 
2. Siani H, Maillard J-Y. Best practice in healthcare environment decontamination. Eur J 
Infect Control Infect Dis 2015;34:1-11. 
3. Le Monnier A, Duburcq A, Zahar JR, et al. Hospital cost of Clostridium difficile infection 
including the contribution of recurrences in French acute-care hospitals. J Hosp Infect 
2015;91:117-122. 
4. Otter JA, Yezli, S, French GL. The role played by contaminated surfaces in the 
transmission of nosocomial pathogens. Infect Control Hosp Epidemiol 2011;32:687-
699. 
5. Weber DJ, Anderson DJ, Sexton DJ, et al. Role of the environment in the transmission 
of Clostridium difficile in health care facilities. Am J Infect Control 2013;41:S105-110. 
6. Weber DJ, Rutala WA, Miller MB, et al. Role of hospital surfaces in the transmission 
of emerging health care-associated pathogens: Norovirus, Clostridium difficile, and 
Acinetobacter species. Am J Infect Control 2010;38:S25-33. 
7. Kundrapu S, Sunkesula V, Jury LA, et al. Daily disinfection of high-touch surfaces in 
isolation rooms to reduce contamination of healthcare workers' hands. Infect Control 
Hosp Epidemiol 2012;33:1039-1042. 
 
 
 
19 
8. Guerrero DM, Nerandzic MM, Jury LA, et al. Acquisition of spores on gloved hands 
after contact with the skin of patients with Clostridium difficile infection and with 
environmental surfaces in their rooms. Am J Infect Control 2012;40:556-558. 
9.  Hardy K, Xa J, Oppenheim B, et al. A Study of the relationship between environmental 
contamination with methicillin-resistant Staphylococcus aureus (MRSA) and patients' 
acquisition of MRSA. Infect Control Hosp Epidemiol 2006;27:127-132. 
10.  Huang SS, Datta R, Platt R. Risk of acquiring antibiotic-resistant bacteria from prior 
room occupants. Arch Intern Med 2006;166:1945-1951. 
11.  Nseir S, Blazejewski C, Lubret R, et al. Risk of acquiring multidrug-resistant Gram-
negative bacilli from prior room occupants in the intensive care unit. Clin Microbiol 
Infect 2011;17:1201-1208. 
12.  Shaughnessy MK, Micielli RL, DePestel DD, et al. Evaluation of hospital room 
assignment and acquisition of Clostridium difficile infection. Infect Control Hosp 
Epidemiol 2011;32:201-206. 
13.  Sattar SA, Maillard J-Y. The crucial role of wiping in decontamination of high-touch 
environmental surfaces: review of current status and directions for the future. Am J 
Infect Control 2013;41:S97-104. 
14.  Williams GJ, Denyer SP, Hosein IK, et al. The development of a new three-step 
protocol to determine the efficacy of disinfectant wipes on surfaces contaminated with 
Staphylococcus aureus. J Hosp Infect 2007;67:329-335. 
 
 
 
20 
15. Williams GJ, Denyer SP, Hosein IK, et al. Limitations of the efficacy of surface 
disinfection in the healthcare settings. Infect Control Hosp Epidemiol 2009;30:570-
573. 
16.  Siani H, Cooper C, Maillard J-Y. Efficacy of “sporicidal” wipes against Clostridium 
difficile. Am J Infect Control 2011;39:212-218. 
17. Ramm L, Siani H, Wesgate R, Maillard J. Pathogen transfer and high variability in 
pathogen removal by detergent wipes. Am J Infect Control 2015;43:724-728. 
18. Cadnum JL, Hurless KN, Kundrapu S, et al. Transfer of Clostridium difficile spores by 
non-sporicidal wipes and improperly used hypochlorite wipes: practice + product = 
Perfection. Infect Control Hosp Epidemiol 2013;34:441-442. 
19.  Sattar SA, Bradley C, Kibbee R, et al. Disinfectant wipes are appropriate to control 
microbial bioburden from surfaces: use of a new ASTM standard test protocol to 
demonstrate efficacy. J Hosp Infect 2015;91:319-325.   
20. Boyce JM, Havill NL. Evaluation of a new hydrogen peroxide wipe disinfectant. Infect 
Control Hosp Epidemiol 2013;34:521-523. 
21. Carter Y, Barry D. Tackling C. difficile with environmental cleaning. Nursing Times 
2010;107:22-25. 
22.  Orenstein R, Aronhalt KC, McManus JE, et al. A targeted strategy to wipe out 
Clostridium difficile. Infect Control Hosp Epidemiol 2011;32:1137-1139. 
23. Boyce JM, Guercia KA, Sullivan L, et al. Prospective cluster controlled crossover trial 
to compare the impact of an improved hydrogen peroxide disnfectant and a quaternay 
 
 
 
21 
ammonium–based disinfectant on surface contamination and healthcare outcomes. 
Am J Infect Control 2017;45:1006-1010. 
24.  Dubberke ER, Reske KA, Noble-Wang J, et al. Prevalence of Clostridium difficile 
environmental contamination and strain variability in multiple health care facilities. Am 
J Infect Control 2007;35:315-318. 
25.  Stegger M, Andersen PS, Kearns A, et al. Rapid detection, differentiation and typing 
of methicillin-resistant Staphylococcus aureus harbouring either mecA or the new 
mecA homologue mecALGA251. Clin Microbiol Infect 2012;18:395-400. 
26. Murakami K, Minamide W, Wada K, et al. Identification of methicillin-resistant strains 
of Staphylococci by polymerase chain reaction. J Clin Microbiol 1991;29:2240-2244. 
27. Cheeseman KE, Williams GJ, Maillard J-Y, et al. Typing of Staphylococcus aureus 
clinical isolates using random amplification of polymorphic DNA method and 
comparison to antibiotic susceptibility typing. J Hosp Infect 2007;67:388-390.  
28. Mulvey D, Redding P, Robertson C, et al. Finding a benchmark for monitoring hospital 
cleanliness. J Hosp Infect 2011;77:25-30. 
29.  Lewis T, Griffith C, Gallo G, Weinbren M. A modified ATP benchmark for evaluating 
the cleaning of some hospital environmental surfaces. J Hosp Infect 2008;69:156-163. 
30. White LF, Dancer SJ, Robertson C, et al. Are hygiene standards useful in, assessing 
infection risk? Am J Infect Control 2008;36:381-384. 
31.  Ray AJ, Deshpande A, Fertelli D, et al. A multicenter randomized trial to determine the 
effect of an environmental disinfection intervention on the incidence of healthcare-
 
 
 
22 
associated Clostridium difficile infection. Infect Control Hosp Epidemiol 2017;38:777-
783. 
32.  Rupp ME, Fitzgerald T, Sholtz L, et al. Maintain the gain: program to sustain 
performance improvement in environmental cleaning. Infect Control Hosp Epidemiol 
2014;35:866-868. 
33. Lewis T, Griffith C, Gallo M, Weinbren M. A modified ATP benchmark for evaluating 
the cleaning of some hospital environmental surfaces. J Hosp Infect 2008;69:156-163.  
34.  Boyce IM, Havill NL, Dumigan DG, et al. Monitoring the effectiveness of hospital 
cleaning practices using an ATP bioluminescence assay. Infect Control Hosp 
Epidemiol 2009;30:678-684. 
35.  Maillard, J-Y. Usage of antimicrobial biocides and products in the healthcare 
environment: efficacy, policies, management and perceived problems. Ther Clin Risk 
Manag 2005;1:307-320. 
36.  Maillard J-Y, S Bloomfield, J Rosado Coelho, et al. (2013) Does microbicide use in 
consumer products promote antimicrobial resistance? A critical review and 
recommendations for a cohesive approach to risk assessment. Microb Drug Res 
2013;19:344-354. 
  
 
 
 
23 
Figure 1 Schematic of double crossover field study. n baseline date: use of standard 
cleaning regimen; n Use of detergent and chlorine 1,000pm; n Use of pre-
impregnated sporicidal wipes; n General training on disinfectant usage, 
wiping and infection prevention; n Specific training on the use of pre-
formulated wipes; n wards closure. 
 
Figure 2 Overall total aerobic and anaerobic counts (Log10 +1/cm
2) and ATP count 
(RLU Log10 +1/cm
2). n Baseline; n Intervention with sporicidal wipe and n 
Cleaning and use of chlorine 1,000 ppm. A) ward 1; B) ward 2 
 
Figure 3 Total counts (Log10/cm
2) per individual sites for ward 1. n Baseline; n 
Intervention with sporicidal wipe (phase 1) and n Cleaning and use of 
chlorine 1,000 ppm (phase 2). A) Total aerobic count; B) total anaerobic 
count. 
 
Figure 4 Total counts (Log10/cm
2) per individual sites for ward 2. n Baseline; n 
Intervention with sporicidal wipe (phase 2) and n Cleaning and use of 
chlorine 1,000 ppm (phase 1). A) Total aerobic count; B) total anaerobic 
count. 
 
Figure 5 Number of sites positive for MDRO. n ESBL; n CRE and n VRE. A) ward 1 
B) ward 2. 
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Fig. 1  
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Fig. 3 A) 
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Fig. 3 B) 
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Fig. 5 A) 
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